These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7349289)

  • 1. Controlled release of prednisolone from ethylene-vinyl acetate copolymer matrix.
    Miyazaki S; Ishii K; Nadai T
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2714-7. PubMed ID: 7349289
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules.
    Sefton MV; Brown LR; Langer RS
    J Pharm Sci; 1984 Dec; 73(12):1859-61. PubMed ID: 6527279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of 5-fluorouracil from hydrophilic ethylene-vinyl alcohol copolymer matrices.
    Miyazaki S; Takeuchi S; Sakamoto M; Takada M
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3707-13. PubMed ID: 6671231
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled drug release from melt-extrudates through processing parameters: a chemometric approach.
    Sarraf AG; Cherkaoui S; Jordan O; Gurny R; Doelker E
    Int J Pharm; 2015 Mar; 481(1-2):9-17. PubMed ID: 25543111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of pilocarpine hydrochloride from ethylene-vinyl alcohol copolymer matrices.
    Hou WM; Miyazaki S; Takada M
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1242-8. PubMed ID: 4028303
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained release of 5-fluorouracil from ethylene acetate copolymer.
    Wyszynski RE; Vahey JB; Manning L; Bruner WE; Morgan KM; Burney EN
    J Ocul Pharmacol; 1989; 5(2):141-6. PubMed ID: 2754299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of insulin from polymer matrices. In vitro kinetics.
    Brown L; Siemer L; Munoz C; Langer R
    Diabetes; 1986 Jun; 35(6):684-91. PubMed ID: 3519323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of release data in the evaluation of the physical state of progesterone in matrix systems.
    Vandelli MA; Forni F; Cameroni R
    J Microencapsul; 1993; 10(1):55-65. PubMed ID: 8445508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release formulation of prednisolone administered orally to man.
    D'Arcy PF; Griffin JP; Jenkins JS; Kirk WF; Peacock AW
    J Pharm Sci; 1971 Jul; 60(7):1028-33. PubMed ID: 4940084
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor effect of ethylene-vinyl acetate copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma in mice.
    Miyazaki S; Ishii K; Sugibayashi K; Morimoto Y; Takada M
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3770-5. PubMed ID: 7160019
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug release from cast films of ethylene vinyl acetate (EVA) copolymer: Stability of drugs by 1H NMR and solid state 13C CP/MAS NMR.
    Kalachandra S; Lin DM; Stejskal EO; Prakki A; Offenbacher S
    J Mater Sci Mater Med; 2005 Jul; 16(7):597-605. PubMed ID: 15965590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.